These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 7386280

  • 1. Partial agonism of prostaglandin H2 analogs and 11-deoxy-prostaglandin F2 alpha to thromboxane-sensitive preparations.
    Jones RL, Wilson NH.
    Adv Prostaglandin Thromboxane Res; 1980; 6():467-75. PubMed ID: 7386280
    [No Abstract] [Full Text] [Related]

  • 2. Reversal of thromboxane A2/prostaglandin H2 and ADP-induced calcium release in intact platelets.
    Brace LD, Venton DL, Le Breton GC.
    Am J Physiol; 1985 Jul; 249(1 Pt 2):H8-13. PubMed ID: 2409821
    [Abstract] [Full Text] [Related]

  • 3. Thromboxane A2/prostaglandin H2 mobilizes calcium in human blood platelets.
    Brace LD, Venton DL, Le Breton GC.
    Am J Physiol; 1985 Jul; 249(1 Pt 2):H1-7. PubMed ID: 3925795
    [Abstract] [Full Text] [Related]

  • 4. Prostaglandin H2 in human platelet activation: coactivator and substitute for thromboxane A2.
    Hornberger WB, Patscheke H.
    Prog Clin Biol Res; 1989 Jul; 301():315-9. PubMed ID: 2798452
    [Abstract] [Full Text] [Related]

  • 5. Thromboxane A2 and the endoperoxides mediate canine platelet activation.
    Harris RH, Nichols R, Schmeling JW, Ramwell PW.
    Thromb Res; 1981 Sep 15; 23(6):521-32. PubMed ID: 6798707
    [No Abstract] [Full Text] [Related]

  • 6. Thromboxane A2/prostaglandin H2 directly stimulates platelet shape change independent of secreted ADP.
    Parise LV, Venton DL, Le Breton GC.
    J Pharmacol Exp Ther; 1982 Jul 15; 222(1):276-81. PubMed ID: 7086705
    [Abstract] [Full Text] [Related]

  • 7. A 16-p-fluorophenoxy prostanoid with potent and long-lasting thromboxane-like actions [proceedings].
    Jones RL, Wilson NH.
    Br J Pharmacol; 1978 Jun 15; 63(2):362P. PubMed ID: 667444
    [No Abstract] [Full Text] [Related]

  • 8. Effects of the prostaglandin H2/thromboxane A2 antagonist BM 13.177 on human platelets.
    Patscheke H, Stegmeier K.
    Adv Prostaglandin Thromboxane Leukot Res; 1985 Jun 15; 13():371-3. PubMed ID: 3159225
    [No Abstract] [Full Text] [Related]

  • 9. Vasoconstrictor response of arterioles of the hamster cheek pouch to norepinephrine, prostaglandin H2, F2 alpha and carbocyclic thromboxane A2, a possible thromboxane A2 analogue.
    Herrmann KS.
    Arch Int Pharmacodyn Ther; 1982 Oct 15; 259(2):180-5. PubMed ID: 6960809
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Thromboxane-induced phosphatidate formation in human platelets. Relationship to receptor occupancy and to changes in cytosolic free calcium.
    Pollock WK, Armstrong RA, Brydon LJ, Jones RL, MacIntyre DE.
    Biochem J; 1984 May 01; 219(3):833-42. PubMed ID: 6234886
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prostaglandin H2 directly lowers human platelet cAMP levels.
    Rybicki JP, Le Breton GC.
    Thromb Res; 1983 Jun 01; 30(5):407-14. PubMed ID: 6310815
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations.
    Coleman RA, Humphrey PP, Kennedy I, Levy GP, Lumley P.
    Br J Pharmacol; 1981 Jul 01; 73(3):773-8. PubMed ID: 7248665
    [Abstract] [Full Text] [Related]

  • 16. From studies of biochemical mechanism to novel biological mediators: prostaglandin endoperoxides, thromboxanes, and leukotrienes. Nobel Lecture, 8 December 1982.
    Samuelsson B.
    Biosci Rep; 1983 Sep 01; 3(9):791-813. PubMed ID: 6315101
    [No Abstract] [Full Text] [Related]

  • 17. [Synthesis of thromboxane A2: limiting stages of primary thrombocyte aggregation in humans initiated by arachidonic acid and its metabolic products].
    Mevkh AT, Basevich VV, Varfolomeev SD.
    Biokhimiia; 1984 Dec 01; 49(12):2035-40. PubMed ID: 6441604
    [Abstract] [Full Text] [Related]

  • 18. Platelet aggregation and exposure of fibrinogen receptors by prostaglandin endoperoxide analogues.
    Morinelli TA, Niewiarowski S, Kornecki E, Figures WR, Wachtfogel Y, Colman RW.
    Blood; 1983 Jan 01; 61(1):41-9. PubMed ID: 6293626
    [No Abstract] [Full Text] [Related]

  • 19. [The antithromboxane activity of alpha- and omega-modified carbocyclic analogs of PGH1].
    Kuz'mitskiĭ BB, Bondar' NF, Malaeva LP.
    Eksp Klin Farmakol; 1992 Jan 01; 55(4):31-3. PubMed ID: 1458183
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and structure of the platelet aggregation factor thromboxane A2.
    Bhagwat SS, Hamann PR, Still WC, Bunting S, Fitzpatrick FA.
    Nature; 1992 Jan 01; 315(6019):511-3. PubMed ID: 4000279
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.